AMRX insider transactions
Amneal Pharmaceuticals Inc. (AMRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for AMRX
- Director Autor Deborah M. sold $450,558 worth of shares (34,819 units at $12.94), decreasing direct ownership by 27% to 93,660 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Buchi J Kevin converted options into 34,819 shares, increasing direct ownership by 86% to 75,077 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Autor Deborah M. converted options into 34,819 shares, increasing direct ownership by 37% to 128,479 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director George Jeffrey P. converted options into 34,819 shares, increasing direct ownership by 11% to 344,614 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Patel Gautam converted options into 34,819 shares, increasing direct ownership by 2% to 1,643,963 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Kiely John converted options into 34,819 shares, increasing direct ownership by 15% to 260,252 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Nark Ted C converted options into 34,819 shares, increasing direct ownership by 12% to 325,848 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Meister Paul M converted options into 48,747 shares, increasing direct ownership by 6% to 832,800 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Yanai Shlomo converted options into 34,819 shares, increasing direct ownership by 12% to 320,804 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Amendment: SEC Form 4 filed by Patel Chintu4/A - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Amendment: SEC Form 4 filed by Patel Chirag K.4/A - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Co-CEO Patel Chintu converted options into 886,468 shares and covered exercise/tax liability with 361,980 shares, increasing direct ownership by 61% to 1,388,521 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- President & Co-CEO Patel Chirag K. covered exercise/tax liability with 350,978 shares and converted options into 886,468 shares, increasing direct ownership by 62% to 1,393,470 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- EVP, Chief Legal Officer Daly Jason B. converted options into 426,819 shares and covered exercise/tax liability with 185,641 shares, increasing direct ownership by 2,274% to 251,784 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President & CFO Konidaris Tasos converted options into 633,865 shares and covered exercise/tax liability with 306,583 shares, increasing direct ownership by 268% to 449,434 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Boyer Andrew S converted options into 548,953 shares and covered exercise/tax liability with 275,307 shares, increasing direct ownership by 180% to 426,072 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Shah Nikita converted options into 508,499 shares and covered exercise/tax liability with 255,109 shares, increasing direct ownership by 173% to 399,793 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- SEC Form 4 filed by Executive Vice President Shah Nikita4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- SEC Form 4 filed by EVP, Chief Legal Officer Daly Jason B.4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- SEC Form 4 filed by Co-CEO Patel Chintu4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- SEC Form 4 filed by Executive Vice President & CFO Konidaris Tasos4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- SEC Form 4 filed by President & Co-CEO Patel Chirag K.4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- SEC Form 4 filed by Executive Vice President Boyer Andrew S4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Nark Ted C sold $586,000 worth of shares (50,000 units at $11.72), decreasing direct ownership by 15% to 291,029 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Shah Nikita exercised 131,856 shares at a strike of $2.75 and sold $1,571,724 worth of shares (131,856 units at $11.92) (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Kiely John sold $295,360 worth of shares (32,000 units at $9.23), decreasing direct ownership by 12% to 225,433 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Shah Nikita sold $1,166,223 worth of shares (120,832 units at $9.65), decreasing direct ownership by 45% to 146,403 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Boyer Andrew S exercised 175,000 shares at a strike of $2.75 and sold $2,619,309 worth of shares (279,244 units at $9.38), decreasing direct ownership by 41% to 152,426 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Shah Nikita sold $666,037 worth of shares (71,694 units at $9.29), decreasing direct ownership by 21% to 267,235 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President & CFO Konidaris Tasos sold $4,663,070 worth of shares (499,730 units at $9.33), decreasing direct ownership by 80% to 122,152 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Shah Nikita sold $452,000 worth of shares (50,000 units at $9.04), decreasing direct ownership by 13% to 338,929 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- EVP, Chief Legal Officer Daly Jason B. sold $199,100 worth of shares (22,000 units at $9.05), decreasing direct ownership by 67% to 10,606 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Boyer Andrew S sold $302,596 worth of shares (33,436 units at $9.05), decreasing direct ownership by 12% to 256,670 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Patel Gautam sold $761,146 worth of shares (94,906 units at $8.02), decreasing direct ownership by 6% to 1,609,144 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Patel Gautam sold $452,537 worth of shares (56,426 units at $8.02), decreasing direct ownership by 3% to 1,704,050 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Shah Nikita sold $372,481 worth of shares (49,140 units at $7.58), decreasing direct ownership by 11% to 388,929 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Kiely John sold $379,500 worth of shares (50,000 units at $7.59), decreasing direct ownership by 16% to 257,433 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Buchi J Kevin converted options into 40,258 shares (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Yanai Shlomo converted options into 40,258 shares, increasing direct ownership by 16% to 285,985 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Autor Deborah M. converted options into 40,258 shares, increasing direct ownership by 75% to 93,660 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Nark Ted C converted options into 40,258 shares, increasing direct ownership by 13% to 341,029 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Kiely John converted options into 40,258 shares, increasing direct ownership by 15% to 307,433 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director George Jeffrey P. converted options into 40,258 shares, increasing direct ownership by 15% to 309,795 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Alva Emily Peterson converted options into 40,258 shares, increasing direct ownership by 24% to 211,029 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Meister Paul M converted options into 56,361 shares, increasing direct ownership by 8% to 784,053 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Patel Gautam converted options into 40,258 shares, increasing direct ownership by 2% to 1,760,476 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Patel Gautam sold $69,344 worth of shares (8,668 units at $8.00), decreasing direct ownership by 0.50% to 1,720,218 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Patel Gautam sold $664,000 worth of shares (80,000 units at $8.30), decreasing direct ownership by 4% to 1,728,886 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Large owner Patel Tushar Bhikhubhai sold $41,750,000 worth of shares (5,000,000 units at $8.35) (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Buchi J Kevin gifted 262,072 shares (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Boyer Andrew S sold $1,111,250 worth of shares (125,000 units at $8.89), decreasing direct ownership by 30% to 290,106 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- EVP, Chief Legal Officer Daly Jason B. sold $792,160 worth of shares (90,000 units at $8.80), decreasing direct ownership by 73% to 32,606 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President & CFO Konidaris Tasos sold $891,000 worth of shares (100,000 units at $8.91), decreasing direct ownership by 14% to 621,882 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Alva Emily Peterson sold $712,000 worth of shares (80,000 units at $8.90), decreasing direct ownership by 32% to 170,771 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- EVP, Chief Legal Officer Daly Jason B. converted options into 187,330 shares and covered exercise/tax liability with 64,724 shares (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President Boyer Andrew S converted options into 284,144 shares and covered exercise/tax liability with 145,342 shares, increasing direct ownership by 50% to 415,106 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Executive Vice President & CFO Konidaris Tasos converted options into 327,770 shares and covered exercise/tax liability with 155,907 shares, increasing direct ownership by 31% to 721,882 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- President & Co-CEO Patel Chirag K. converted options into 672,302 shares and covered exercise/tax liability with 326,888 shares, increasing direct ownership by 67% to 857,980 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Co-CEO Patel Chintu converted options into 672,302 shares and covered exercise/tax liability with 320,835 shares, increasing direct ownership by 69% to 864,033 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)
- Director Patel Gautam sold $712,000 worth of shares (80,000 units at $8.90), decreasing direct ownership by 4% to 1,808,886 units (SEC Form 4)4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)